col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


35 Results       Page 1

 [1] 
Springer-Verlag: Advances in Therapy
  original article Date Title Authors   All Authors
1 [GO] 2022―May―04 Changes in Refractive Error Under COVID-19: A 3-Year Follow-up Study Xiaoyan Yang, Qian Fan, Yue Zhang, Xiaoqin Chen, Yanglin Jiang, Haohan Zou, et al. (+3)
2 [GO] 2022―Apr―13 Efficacy and Safety of ELOM-080 as Add-On Therapy in COVID-19 Patients with Acute Respiratory Insufficiency: Exploratory Data from the Prospective Placebo-Controlled COVARI Trial Michael Dreher, Christian Grohè, Niels-Ulrik Hartmann, Stephan Kanzler, Karin Kraft, Christoph Sarrazin, et al. (+10)
3 [GO] 2022―Mar―14 Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era Stefan Schreiber, Shomron Ben-Horin, Rieke Alten, René Westhovens, Laurent Peyrin-Biroulet, Silvio Danese, et al. (+7)
4 [GO] 2022―Feb―14 Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic Monica Fletcher, Thys van der Molen, Warren Lenney, Isabelle Boucot, Bhumika Aggarwal, Emilio Pizzichini
5 [GO] 2022―Feb―12 Correction to: The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens Bo Jiang, Lin Gao, Su Dong, Qingxue Hou, Minghao Sun, Jingjie Zhang, et al. (+3)
6 [GO] 2022―Jan―24 A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab Lucinda Villaescusa, Francisco Zaragozá, Irene Gayo-Abeleira, Cristina Zaragozá
7 [GO] 2022―Jan―06 Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era Stefan Schreiber, Shomron Ben-Horin, Rieke Alten, René Westhovens, Laurent Peyrin-Biroulet, Silvio Danese, et al. (+7)
8 [GO] 2021―Dec―15 Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan Kuan-Yuan Chen, Kang-Yun Lee, Albert Qin, Ching-Shan Luo, Yun-Kai Yeh, Jing-Quan Zheng, et al. (+6)
9 [GO] 2021―Nov―24 The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens Bo Jiang, Lin Gao, Su Dong, Qingxue Hou, Minghao Sun, Jingjie Zhang, et al. (+3)
10 [GO] 2021―Nov―22 Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study Kari Kelton, Tim Klein, Dan Murphy, Mark Belger, Erik Hille, Patrick L. McCollam, et al. (+2)
11 [GO] 2021―Nov―18 Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era Patricia K. Coyle, Anne Gocke, Megan Vignos, Scott D. Newsome
12 [GO] 2021―Oct―05 Inpatient Hospital Costs for COVID-19 Patients in the United States Robert L. Ohsfeldt, Casey Kar-Chan Choong, Patrick L. Mc Collam, Hamed Abedtash, Kari A. Kelton, Russel Burge
13 [GO] 2021―Sep―13 Healthcare Resource Use in Patients with Immune-Mediated Conditions Treated with Targeted Immunomodulators During COVID-19 Pandemic: A Retrospective Claims Analysis Martin Bergman, Christopher D. Saffore, Katherine J. Kim, Pankaj A. Patel, Vishvas Garg, Si Xuan, Haley B. Naik
14 [GO] 2021―Aug―23 Experimental and Compassionate Drug Use During the First Wave of the COVID-19 Pandemic: A Retrospective Single-Center Study Or Assouline, Eli Ben-Chetrit, Yigal Helviz, Ramzi Kurd, Marc Leone, Sharon Einav
15 [GO] 2021―Aug―11 Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey Ergun Oksuz, Simten Malhan, Mustafa Sait Gonen, Zekayi Kutlubay, Yilmaz Keskindemirci, James Jarrett, et al. (+5)
16 [GO] 2021―Jul―18 Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service Rebecca C. Robey, Katie Kemp, Philip Hayton, Dalia Mudawi, Ran Wang, Melanie Greaves, et al. (+4)
17 [GO] 2021―Jun―26 Endotracheal Application of Ultraviolet A Light in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2: A First-in-Human Study Ali Rezaie, Gil Y. Melmed, Gabriela Leite, Ruchi Mathur, Will Takakura, Isabel Pedraza, et al. (+4)
18 [GO] 2021―Jun―12 Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain Alejandro Soriano, Rocío Montejano, José Sanz-Moreno, Juan Carlos Figueira, Santiago Grau, Robert Güerri-Fernández, et al. (+4)
19 [GO] 2021―Jun―04 Platelet Reactivity and Coagulation Markers in Patients with COVID-19 Adriadne J. Bertolin, Talia F. Dalçóquio, Rocío Salsoso, Remo H. de M. Furtado, Roberto Kalil-Filho, Ludhmila A. Hajjar, et al. (+12)
20 [GO] 2021―Jun―01 Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era Patricia K. Coyle, Anne Gocke, Megan Vignos, Scott D. Newsome
21 [GO] 2021―May―07 A Retrospective Study of COVID-19-Related Urgent Medical Visits and Hospitalizations After Outpatient COVID-19 Diagnosis in the US Wenhui Wei, Sumathi Sivapalasingam, Scott Mellis, Gregory P. Geba, Jessica J. Jalbert
22 [GO] 2021―Apr―14 Can Thoracic Ultrasound on Admission Predict the Outcome of Critically Ill Patients with SARS-CoV-2? A French Multi-Centric Ancillary Retrospective Study Gary Duclos, Florian Bazalguette, Bernard Allaouchiche, Neyla Mohammedi, Alexandre Lopez, Mathieu Gazon, et al. (+8)
23 [GO] 2021―Apr―01 Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment: An Observational Study Showing that Things Are Not Always as They Seem Massimo Cugno, Roberta Gualtierotti, Giovanni Casazza, Francesco Tafuri, Gabriele Ghigliazza, Adriana Torri, et al. (+3)
24 [GO] 2021―Mar―01 A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States Daniel Sheinson, Joseph Dang, Anuj Shah, Yang Meng, David Elsea, Stacey Kowal
25 [GO] 2021―Jan―18 Post Abortion Care and Management After Induced Abortion During the COVID-19 Pandemic: A Chinese Expert Consensus Yu Wang, Qing Yang
26 [GO] 2020―Dec―26 Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource Utilization Daniel M. Sheinson, William B. Wong, Caroline E. Solon, Mindy M. Cheng, Anuj Shah, David Elsea, Yang Meng
27 [GO] 2020―Oct―27 Design and Rationale of a Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study Evaluating Dociparstat in Acute Lung Injury Associated with Severe COVID-19 Joseph A. Lasky, Jyotsna Fuloria, Marion E. Morrison, Randall Lanier, Odin Naderer, Tom Brundage, Allen Melemed
28 [GO] 2020―Oct―12 Baseline Demographics and Clinical Characteristics Among 3471 US Patients Hospitalized with COVID-19 and Pulmonary Involvement: A Retrospective Study Jennie H. Best, Shalini V. Mohan, Amanda M. Kong, Krish Patel, John M. Pagel, Boris Ivanov, et al. (+4)
29 [GO] 2020―Aug―27 Preparing the Burns Unit to Accommodate Vaginal Delivery and Cesarean Section for Pregnant Women with COVID-19: A Successful Experience from Jordan Omar Altal, Diab Bani Hani, Abdelwahab Aleshawi, Ala”a Alhowary, Basil Obeidat, Majid Bani-Ata
30 [GO] 2020―Aug―18 Novel Insights into the Transmission of SARS-CoV-2 Through the Ocular Surface and its Detection in Tears and Conjunctival Secretions: A Review Noemi Güemes-Villahoz, Barbara Burgos-Blasco, Beatriz Vidal-Villegas, Julián Garcia-Feijoo, Pedro Arriola-Villalobos, Jose María Martínez-de-la-Casa, et al. (+2)
31 [GO] 2020―Aug―18 Perspectives on the Early Quality of Evidence Guiding the Therapeutic Management of SARS-CoV-2: A Systematic Literature Review Kaushik Subramanian, Anuradha Nalli, Vinitha Senthil, Saurabh Jain, Aravind Nayak, Amit Bhat
32 [GO] 2020―Jul―06 Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature Leili Rahimi, Mojtaba Malek, Faramarz Ismail-Beigi, Mohammad E. Khamseh
33 [GO] 2020―Jun―05 Dysfunctional Coagulation in COVID-19: From Cell to Bedside Jie Wang, Ardan M. Saguner, Jiaqi An, Yuye Ning, Yang Yan, Guoliang Li
34 [GO] 2020―Apr―29 Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action Zakir Khan, Yusuf Karataş, Hazir Rahman
35 [GO] 2020―Apr―01 Warning Against the Use of Anti-Inflammatory Medicines to Cure COVID-19: Building Castles in the Air Giustino Varrassi
 [1] 

35 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.011 sec